Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS)
Open accessThe DOI matches its Crossref record; 124 of the 129 references it cites were found in a registry or an index; 94 of the 261 sources its claims cite were checked for support.
Abstract
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder experienced by women. PCOS is a lifelong condition associated with reproductive, metabolic, and psychological presentations. PCOS is also linked with increased prevalence of cardiometabolic risk factors. While an association between body weight and PCOS has been noted, cardiometabolic risk factors are prevalent in individuals with PCOS across body weights. Currently, no consensus exists as to the most appropriate lifestyle strategy for mitigating cardiometabolic risk in PCOS. A large proportion of the literature is focused on weight loss for individuals with PCOS who are overweight or experience obesity, despite PCOS being prevalent across body sizes. The aim of this narrative review is to assess dietary and lifestyle interventions aimed at reducing cardiometabolic risk in individuals with PCOS across body sizes. A total of 51 articles are included in this review. Overall, randomized controlled trials are limited and most studies focus on weight loss, excluding individuals classified within a healthy body weight range. Studies that modified the dietary pattern without an energy deficit saw improvements in cardiometabolic risk. Thus, less restrictive dietary approaches may be effective at reducing cardiometabolic risk in this population. This review also highlights the need for more sustainable lifestyle interventions that meet the needs of individuals with PCOS of varying body weights.
Overview
CoChat Summary
## TL;DR
This narrative review summarizes 51 dietary and lifestyle intervention studies in PCOS and concludes that cardiometabolic risk can improve even without intentional weight loss, especially when dietary patterns are changed without an energy deficit. However, most studies were small, short, and focused on overweight/obesity, so the evidence does not support one best approach for all body sizes.
## Key findings
- The review included 51 studies: 37 dietary interventions and 14 lifestyle interventions.
- Randomized controlled trials were limited: only 13 dietary and 6 lifestyle interventions were randomized.
- Studies that changed dietary patterns without an energy deficit reported improvements in cardiometabolic risk factors, and the authors conclude these may be more realistic and sustainable across body sizes.
- Several specific interventions were associated with improved markers, including:
- VLCDs (about 450–800 kcal/day) improving weight and, in some studies, glucose and insulin measures.
- Low-carbohydrate diets lowering fasting insulin, glucose, total cholesterol, LDL-C, HOMA-IR, and insulin area under the curve.
- An energy-restricted DASH diet improving weight, BMI, insulin, and in one study triglycerides and VLDL cholesterol.
- The review notes that many lifestyle interventions combining diet + exercise improved outcomes such as weight, BMI, waist circumference, blood pressure, HOMA-IR, glucose, insulin, triglycerides, total cholesterol, LDL-C, and HDL-C.
## Methods
- Narrative review of intervention studies on dietary and lifestyle management for cardiometabolic risk in PCOS.
- Literature search conducted between June 2021 and April 2023 in PubMed and CINAHL; limited to original human studies in English published 1989–2023.
- Included adult individuals with PCOS across weight and BMI ranges, and studies had to report at least one anthropometric measure plus one biochemical or clinical cardiometabolic marker; studies were grouped into dietary versus lifestyle interventions.
## Limitations
- The paper states the review searched only two databases and did not include conference proceedings, abstracts, government publications, or theses.
- The included studies used different PCOS diagnostic criteria, and the results were not systematically reviewed and analyzed.
- Evident from the text: many included studies were small, short, often lacked control groups, had high attrition, and frequently focused on people with overweight/obesity, which limits generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
65 Valid · 5 Not valid · 48 Not checked · 63 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“three lacked a control group [88,89,92]”
§ Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) > 3. Results > 3.1. Dietary Interventions
What the sources say
- Disputedcites [88] Almario, 2009, Effects of Protein versus Simple Sugar Intake on Weight Loss in Polycystic Ovary Syndrome (According to the National Institutes of Health Criteria), Fertil. Steril. sourceExperimental — accuracy not yet measured
The Results (page not provided) state that 33 participants were randomized to a protein group or a simple-sugars group. The Study Design describes a comparison between those two diets, so this study had a comparison group, although it did not include an untreated group. The cited paper also cannot establish whether the other two studies lacked control groups. (LLM, conf=0.86)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [89] Moran, 2003, Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome, J. Clin. Endocrinol. Metab. source
- Not checked — no full text of the sourcecites [92] Stamets, 2004, A Randomized Trial of the Effects of Two Types of Short-Term Hypocaloric Diets on Weight Loss in Women with Polycystic Ovary Syndrome, Fertil. Steril. source
plainn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“While an association between body weight and PCOS has been noted [18], cardiometabolic risk factors are prevalent in individuals with PCOS across varying body weights [19,26]”
§ Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) > 1. Introduction
What the sources say
- Supportedcites [19] Osibogun, 2020, Polycystic Ovary Syndrome and Cardiometabolic Risk: Opportunities for Cardiovascular Disease Prevention, Trends Cardiovasc. Med. source
The Overweight/Obesity section states that non-obese women with PCOS are also at increased risk of cardiometabolic abnormalities, although obesity worsens them. The Introduction reports insulin resistance in both obese and lean women with PCOS, supporting the claim across body weights. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [26] Zhu, 2019, Metabolic Disturbances in Non-Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis, Fertil. Steril. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“observational studies that have included individuals with PCOS with a healthy BMI (18.5–24.9 kg/m2) still identified a higher prevalence of cardiometabolic risk factors between individuals with and without PCOS [10,11,21,22,23,25,28,30,31,33].”
§ Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) > 1. Introduction
What the sources say
- Supportedcites [10] Toscani, 2011, Insulin Resistance Is Not Strictly Associated with Energy Intake or Dietary Macronutrient Composition in Women with Polycystic Ovary Syndrome, Nutr. Res. source
The Results report that normal-weight participants were included in both the PCOS and control groups (18% and 19%, respectively). They also report more insulin resistance in the PCOS group and higher levels of several cardiometabolic risk markers. These are whole-group comparisons, not findings specific to the normal-weight participants. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [11] Wang, 2022, Higher Dietary Inflammation Potential and Certain Dietary Patterns Are Associated with Polycystic Ovary Syndrome Risk in China: A Case-Control Study, Nutr. Res. source
- Supportedcites [21] Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., and Savastano, S. (2019). Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients, 11. source
The Population Study section includes normal-weight women, and the anthropometric methods define normal weight as BMI 18.5–24.9 kg/m². The Results report that the BMI-matched PCOS group had higher fasting insulin, glucose, and HOMA-IR, and that more women with PCOS exceeded the waist-circumference cutoff than controls. These are comparisons of the full groups, not a separate normal-weight subgroup. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [22] Graff, 2013, Dietary Glycemic Index Is Associated with Less Favorable Anthropometric and Metabolic Profiles in Polycystic Ovary Syndrome Women with Different Phenotypes, Fertil. Steril. source
- Partly supportedcites [23] Cutler, 2019, Low Intakes of Dietary Fiber and Magnesium Are Associated with Insulin Resistance and Hyperandrogenism in Polycystic Ovary Syndrome: A Cohort Study, Food Sci. Nutr. sourceExperimental — accuracy not yet measured
The Results (Participants with PCOS, Table 2; page unavailable) include 25 women with PCOS in the normal-BMI category. The Results (All participants; page unavailable) report higher BMI and waist-to-hip ratio in women with PCOS than in women without PCOS, but do not compare cardiometabolic risk-factor prevalence between the normal-BMI PCOS group and controls. Thus the healthy-BMI inclusion and an overall risk-factor difference are supported, but the claimed prevalence finding in that context is not. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [25] Kulshreshtha, 2022, PCOS Patients Differ in Meal Timings Rather than Total Caloric or Macronutrient Intake in Comparison to Weight Matched Controls, Eur. J. Obstet. Gynecol. Reprod. Biol. source
- Not checked — no full text of the sourcecites [28] Ribeiro, 2019, Dietary Intake, Body Composition and Metabolic Parameters in Women with Polycystic Ovary Syndrome, Clin. Nutr. Edinb. Scotl. source
- Not checked yetcites [30] Houjeghani, 2015, Relationship between Serum Leptin, Ghrelin and Dietary Macronutrients in Women with Polycystic Ovary Syndrome, Int. J. Fertil. Steril.
- Not checked — no full text of the sourcecites [31] Hart, 2016, Suboptimal Dietary Intake Is Associated with Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: PCOS and Suboptimal Dietary Intake, Nutr. Diet. source
- Partly supportedcites [33] Polak, A.M., Krentowska, A., Łebkowska, A., Buczyńska, A., Adamski, M., Adamska-Patruno, E., Fiedorczuk, J., Krętowski, A.J., Kowalska, I., and Adamska, A. (2020). The Association of Serum Levels of Leptin and Ghrelin with the Dietary Fat Content in Non-Obese Women with Polycystic Ovary Syndrome. Nutrients, 12. sourceExperimental — accuracy not yet measured
The Introduction states that women with PCOS have a higher risk of metabolic syndrome and type 2 diabetes than the general population. But the Discussion (page unavailable) says this study’s non-obese PCOS and control groups did not differ in glucose, insulin, HOMA-IR, or serum lipids. It does not establish a higher prevalence of cardiometabolic risk factors specifically among women with a healthy BMI. (LLM, conf=0.84)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The level of central adiposity likely plays a key role in cardiometabolic risk, as insulin resistance has been associated with higher levels of central adiposity in the PCOS population [32,34,35,36].”
§ Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) > 1. Introduction
What the sources say
- Partly supportedcites [32] Cassar, 2016, Insulin Resistance in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Euglycaemic–Hyperinsulinaemic Clamp Studies, Hum. Reprod. sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that higher BMI exacerbated insulin resistance in PCOS and suggests greater visceral fat as a possible explanation, at least among overweight and obese women. It does not establish an association between measured central adiposity and insulin resistance across the PCOS population, or directly assess cardiometabolic risk. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [34] Lord, 2006, The Central Issue? Visceral Fat Mass Is a Good Marker of Insulin Resistance and Metabolic Disturbance in Women with Polycystic Ovary Syndrome, BJOG Int. J. Obstet. Gynaecol. source
- Partly supportedcites [35] Kalra, 2009, Abdominal Fat Distribution and Insulin Resistance in Indian Women with Polycystic Ovarian Syndrome, Fertil. Steril. sourceExperimental — accuracy not yet measured
Kalra et al. (2009) support the association part of the sentence: in 37 Indian women with PCOS, HOMA-IR correlated with waist circumference (r = 0.35, P = .04) and waist circumference was significantly associated with IR on univariate and multivariate clinical-parameter analysis (OR 1.63, 95% CI 1.13-2.35, P = .009; Results/Table 2, Abstract). However, when abdominal compartments were directly measured, visceral (central) fat was NOT independently associated with IR (correlation r = 0.32, P = .055; only subcutaneous fat showed an independent association), and the paper's stated conclusion is that subcutaneous abdominal fat was the best marker of IR — so it does not carry the 'central adiposity plays a key role' framing. The discussion (Abstract) also notes that previously 'an association with central obesity has not been reported' in South Asian women with PCOS, and no cardiometabolic-risk outcome was measured in this single-centre, n = 37 sample. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [36] Karabulut, 2012, Evaluation of Body Fat Distribution in PCOS and Its Association with Carotid Atherosclerosis and Insulin Resistance, Gynecol. Endocrinol. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“observational studies that included BMI-matched controls still identified a higher prevalence of cardiometabolic risk factors in individuals with PCOS, irrespective of BMI [10,21,28,29,30,31].”
§ Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS) > 1. Introduction
What the sources say
- Supportedcites [10] Toscani, 2011, Insulin Resistance Is Not Strictly Associated with Energy Intake or Dietary Macronutrient Composition in Women with Polycystic Ovary Syndrome, Nutr. Res. source
The Introduction describes a case-control study with BMI-matched controls. The Results report more insulin resistance in the PCOS group (53% versus 5.5%) and higher glucose, insulin, triglycerides, and cholesterol despite similar BMI. The Discussion cautions that this predominantly overweight or obese sample cannot establish the study’s findings for lean women. (LLM, conf=0.90)
- Supportedcites [21] Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., and Savastano, S. (2019). Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients, 11. source
The Results (§3) compare women with PCOS against age- and BMI-matched controls and report higher fasting insulin, glucose, and HOMA-IR, as well as more women with waist circumference above the cutoff. This observational study therefore supports the cited point that cardiometabolic risk indicators differed despite BMI matching. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [28] Ribeiro, 2019, Dietary Intake, Body Composition and Metabolic Parameters in Women with Polycystic Ovary Syndrome, Clin. Nutr. Edinb. Scotl. source
- Not checked — no full text of the sourcecites [29] Douglas, 2006, Difference in Dietary Intake between Women with Polycystic Ovary Syndrome and Healthy Controls, Fertil. Steril. source
- Not checked yetcites [30] Houjeghani, 2015, Relationship between Serum Leptin, Ghrelin and Dietary Macronutrients in Women with Polycystic Ovary Syndrome, Int. J. Fertil. Steril.
- Not checked — no full text of the sourcecites [31] Hart, 2016, Suboptimal Dietary Intake Is Associated with Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: PCOS and Suboptimal Dietary Intake, Nutr. Diet. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
88 more claims · 24 with their cited sources checked
Create a free account to see all 181 claims and to verify the 27 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 23
- The quote only partly states this claim. 1
Citations
Cites
‘Small Changes' to Diet and Physical Activity Behaviors for Weight Management
Hills, A. P., Byrne, N. M., Lindstrom, R., & Hill, J. O. (2013) · Obesity Facts · doi:10.1159/000345030 · Cited by 9,493
Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., Lizneva, D., Natterson-Horowtiz, B., Teede, H. J., & Yildiz, B. O. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.57 · Cited by 2,005 · cited 5×
“With a large proportion of research being conducted in medical centers [4,18,39], individuals at higher body weights may present with worse clinical presentations and perhaps are more likely to be diagnosed [18], referred to other providers [4,48,49], and ultimately included in the research.”
BackgroundInfluentialTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Medicare's search for effective obesity treatments: Diets are not the answer.
Mann, T., Tomiyama, A. J., Westling, E., Lew, A.-M., Samuels, B., & Chatman, J. (2007) · American Psychologist · doi:10.1037/0003-066x.62.3.220 · Cited by 1,208
Moran, L. J., Misso, M. L., Wild, R. A., & Norman, R. J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq001 · Cited by 1,108 · cited 1×
“PCOS is linked with increased prevalence of cardiometabolic risk factors, including dyslipidemia [10–13], hypertension [13–15], chronic inflammation, and impaired glucose tolerance [16,17], as well as overweight and obesity [18,19].”
BackgroundLichtenstein, A. H., Appel, L. J., Vadiveloo, M., Hu, F. B., Kris-Etherton, P. M., Rebholz, C. M., Sacks, F. M., Thorndike, A. N., Van Horn, L., Wylie-Rosett, J., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001031 · Cited by 1,065
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., et al. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad463 · Cited by 946 · cited 9×
“…PCOS, overall, clinicians should promote the adoption of healthy lifestyle behaviors that include adequate physical activity and a varied, flexible diet that meets nutritional needs, individual preferences, and cultural considerations, while avoiding unduly restrictive, unbalanced diet patterns [1].”
BackgroundMethodInfluentialLim, S. S., Davies, M. J., Norman, R. J., & Moran, L. J. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms030 · Cited by 939 · cited 8×
“Similarly, the literature tends to only include overweight or obese individuals as study participants [18,39,43,47].”
BackgroundInfluentialKiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921 · cited 4×
“While all of the included studies found VLCDs effective for weight loss [60–65], many of the studies are over 20 years old [60,61,63,65], lack a control group [61–65], do not describe the demographic characteristics of participants [60–65], and have relatively small sample sizes [60–63,65…”
BackgroundResultInfluentialLevine, G. N., Cohen, B. E., Commodore-Mensah, Y., Fleury, J., Huffman, J. C., Khalid, U., Labarthe, D. R., Lavretsky, H., Michos, E. D., Spatz, E. S., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000947 · Cited by 865
Cited by
Therapeutic Potential of Olive Leaf Extracts: A Comprehensive Review
de Oliveira, N. M., Machado, J. P., Chéu, M. H., Lopes, L. T., & Criado, M. B. (2024) · Applied Biosciences · doi:10.3390/applbiosci3030026 · Cited by 43
“Lifestyle measures, including diet modification, show positive effects on CVD, CHD, obesity, hepatic steatosis, and other metabolic comorbidities in women with PCOS [244,245].”
Li, M., Zhang, L., Li, X., & Zhao, Y. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16178 · Cited by 10
Choi, Y.-J., Kang, K., Je, M., Lee, Y., & Kim, Y. (2025) · Nutrients · doi:10.3390/nu17040674 · Cited by 16
Scannell, N., Mantzioris, E., Cowan, S., Moran, L., & Villani, A. M. (2025) · Proceedings of The Nutrition Society · doi:10.1017/s0029665126104054 · Cited by 9
Meliani-Rodríguez, A., Cutillas-Tolín, A., Mendiola, J., Sánchez-Ferrer, M. L., Sánchez, E. D. L. C., Vioqué, J., & Torres-Cantero, A. M. (2024) · Nutrients · doi:10.3390/nu16142238 · Cited by 5
“…risk factor for other metabolic and psychological disorders, such as hyperinsulinemia and type 2 diabetes [2], obesity [3], cardiovascular disease [4], gut microbiota dysbiosis [5], decreased quality of life [6], and mental health problems, such as depression, anxiety, eating disorders, and…”
Background
Metadata
- Authors
- Herbert, S., & Woolf, K.
- Affiliations
- New York University (US)
- Corresponding author
- Woolf, Kathleen
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2023-12-11
- Volume
- 15
- Issue
- 24
- Pages
- 5069
- ISSN
- 2072-6643 (ISSN-L)
- PMC
- PMC10745999
- OpenAlex
- W4389546415
- Semantic Scholar
- 51ec3a91de5dcff2e324e17bd0075836ef95c380
- Cited by
- 15
- References
- 129
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrients (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, cardiometabolic risk, dietary intervention, lifestyle intervention, weight loss, body weight, obesity, overweight, negative energy balance
- MeSH terms
- Cardiovascular Diseases, Female, Humans, Life Style, Obesity, Polycystic Ovary Syndrome, Weight Loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS). https://app.cochat.ai/papers/10.3390/nu15245069
- The paper
- Herbert, S., & Woolf, K. (2023). Moving beyond Weight: A Narrative Review of the Dietary and Lifestyle Management for Reducing Cardiometabolic Risk in Polycystic Ovary Syndrome (PCOS). Nutrients. https://doi.org/10.3390/nu15245069
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.